Hikma Pharmaceutical | Spese Operative



Operating Expenses Cambiamento Data
Almirall EUR 485.13M 289.74M 2024-12
argenx SE USD 651.74M 16.37M 2025-03
AstraZeneca USD 9.91B 2.94B 2025-03
Autolus Therapeutics Ltd 74.22M 1.67M 2025-03
Bayer EUR 11.41B 3.22B 2025-03
Fresenius EUR 4.96B 197M 2025-03
Galapagos EUR 233.68M 95.46M 2025-03
Genmab DKK 527M 3.72B 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
GRIFOLS EUR 1.52B 87M 2025-03
Hikma Pharmaceutical USD 1.24B 87M 2024-06
Lonza CHF 2.52B 776M 2024-06
Merck EUR 4.22B 52M 2024-12
Orion EUR 276.7M 65M 2025-03
Recordati EUR 484.19M 89.46M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
UCB EUR 1.23B 1.31B 2024-06



Hikma Pharmaceutical Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.